iQ Group claims to have saliva-based connected non-invasive glucometer. The iQ Group, an Australian consortium of life sciences companies, is developing a smartphone-connected real-time glucose monitoring test that uses saliva, rather than blood. Glucose levels in bodily fluids like saliva, sweat, and tears can serve as a reasonable proxy for blood glucose, but so far the many attempts at making...
Apple versus posionous gas. Patently Apple has spotted a newly published patent application that seems to suggest that miniature sensors for poisonous gas may be a feature of future Apple devices.
Filled in March of 2018, the application’s diagrams include examples of the sensors housed within an enclosure such as an Apple Watch and describe detection capabilities for “at least one of ozone (O....
Laid to rest. A longstanding legal dispute between Apple and Valencell over infringement on four patents and deceptive trade practices was quietly put to bed last year. The two companies submitted their dismissal to the US District Court North Carolina in September, with no other details on how the settlement shook out.
When this case (and a similar one against Fitbit) was first filed in early...
A bot by any other name. It appears that Pillo Health won’t be the only one selling its friendly home health assistant and countertop pill dispenser. Thanks to a strategic investment by Stanley Ventures, Stanley Black & Decker will be offering a slightly modified version of the device under the name of “Pria by Black+Decker Home Care Companion.” According to a representative of Stanley Black...
Clearance expands BrainScope's use cases. Bethesda, Maryland-based BrainScope has received FDA clearance for new labeling for its BrainScope One system, a wearable mobile device that helps medical professionals assess traumatic brain injury. Specifically, the new labelling expands the product's indications for use to include “multi-modal, multi-parameter assessment” of “concussion” and “mild...
Owkin, the predictive analytics startup backed by Alphabet’s GV, has announced the launch of its AI-powered medical research network. Comprised of 30 US and EU hospitals and research institutions, the Owkin Loop Network looks to help researchers train their predictive health models on a greater scale of real-world data, as well as share any insights gained between participating researchers and...
De Novo rule proposal published for review. The FDA has published a new proposal for revisions to the De Novo regulatory pathway for devices without a predicate. The rule, which is currently available for public comment, aims to provide additional structure, clarity and transparency to the process, and outlines how the agency processes and gauges submitted devices.
“Our goal is to make the De...
Livongo’s DPP recogized by the CDC. Digital chronic care company Livongo Health’s Diabetes Prevention Program has received full recognition from the CDC, according to a release from the company. The designation implies that the digital offering meets the agency’s standards as a Type 2 diabetes prevention and lifestyle change intervention, and is listed within the CDC’s online referral tool.
“CDC...
Point-and-shoot wound imaging. Earlier this week, mobile imaging and AI platform Tissue Analytics has revealed a new feature that can generate a 3D image of a patient's wound from a five-second smartphone video. Once made, these images can be easily shared to EMRs through the platform’s integration Cerner, Epic, athenahealth, and Allscripts.
"Tissue Analytics uses sophisticated algorithms that...
A peak at Withings' next device? Rumor has it Withings is creating a new fitness tracker at a lower price point. Wearable reports that a tracker listed by the company as Pulse HR in a recent FCC filing, which could indicate that it will have a heart rate monitor.
For the last two year Withings has been part of Nokia’s digital health division. But the department faced challenges from the get go...
